Search research articles
Contact Us
Filters
Showing results (71-80 of 225) with videos related to
Page
of 23
Sort By:
VASA. Zeitschrift Fur Gefasskrankheiten
|
July 17, 2018
Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy
Jan Beyer-Westendorf, Rupert Bauersachs, Viola Hach-Wunderle, et al.
Deutsches Arzteblatt International
|
March 6, 2019
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism
Jan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, et al.
The American Journal of Medicine
|
November 19, 2021
First Trimester Anticoagulant Exposure and Adverse Pregnancy Outcomes in Women with Preconception Venous Thromboembolism: A Nationwide Cohort Study
Mette Søgaard, Flemming Skjøth, Peter Brønnum Nielsen, et al.
Thrombosis Research
|
June 15, 2015
Coagulation activation after discontinuation of VTE treatment with different oral anticoagulants and impact on 12-month clinical outcomes
Jan Beyer-Westendorf, Siegmund Gehrisch, Thoralf Stange, et al.
Journal of Gastroenterology
|
February 18, 2017
Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs
Sven Pannach, Julia Goetze, Sandra Marten, et al.
The American Journal of Medicine
|
March 13, 2018
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism
Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Physical Chemistry Chemical Physics : PCCP
|
July 17, 2019
Extending the temperature sensing range using Eu<sup>3+</sup> luminescence up to 865 K in a single crystal of EuPO<sub>4</sub>
Suchinder K Sharma, Thomas Köhler, Jan Beyer, et al.
Journal of Thrombosis and Thrombolysis
|
March 15, 2016
Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial
Sebastian Werth, Rupert Bauersachs, Horst Gerlach, et al.
International Journal of Cardiology
|
March 7, 2018
Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry
Loretta Keller, Sandra Marten, Judith Hecker, et al.
Journal of Thrombosis and Thrombolysis
|
October 12, 2014
Outpatient or inpatient treatment for acute pulmonary embolism: a retrospective cohort study of 439 consecutive patients
Sebastian Werth, Virginia Kamvissi, Thoralf Stange, et al.
Page
of 23
Search research articles
Search
Showing results (71-80 of 225) with videos related to
Sort By:
Page
of 23
VASA. Zeitschrift Fur Gefasskrankheiten
|
July 17, 2018
Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy
Jan Beyer-Westendorf, Rupert Bauersachs, Viola Hach-Wunderle, et al.
Deutsches Arzteblatt International
|
March 6, 2019
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism
Jan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, et al.
The American Journal of Medicine
|
November 19, 2021
First Trimester Anticoagulant Exposure and Adverse Pregnancy Outcomes in Women with Preconception Venous Thromboembolism: A Nationwide Cohort Study
Mette Søgaard, Flemming Skjøth, Peter Brønnum Nielsen, et al.
Thrombosis Research
|
June 15, 2015
Coagulation activation after discontinuation of VTE treatment with different oral anticoagulants and impact on 12-month clinical outcomes
Jan Beyer-Westendorf, Siegmund Gehrisch, Thoralf Stange, et al.
Journal of Gastroenterology
|
February 18, 2017
Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs
Sven Pannach, Julia Goetze, Sandra Marten, et al.
The American Journal of Medicine
|
March 13, 2018
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism
Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Physical Chemistry Chemical Physics : PCCP
|
July 17, 2019
Extending the temperature sensing range using Eu<sup>3+</sup> luminescence up to 865 K in a single crystal of EuPO<sub>4</sub>
Suchinder K Sharma, Thomas Köhler, Jan Beyer, et al.
Journal of Thrombosis and Thrombolysis
|
March 15, 2016
Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial
Sebastian Werth, Rupert Bauersachs, Horst Gerlach, et al.
International Journal of Cardiology
|
March 7, 2018
Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry
Loretta Keller, Sandra Marten, Judith Hecker, et al.
Journal of Thrombosis and Thrombolysis
|
October 12, 2014
Outpatient or inpatient treatment for acute pulmonary embolism: a retrospective cohort study of 439 consecutive patients
Sebastian Werth, Virginia Kamvissi, Thoralf Stange, et al.
Page
of 23